MaxCyte launches CHANGE-seq-BE and ONE-seq-BE assays
MaxCyte (NASDAQ: MXCT) announces the launch of CHANGE-seq-BE and ONE-seq-BE off-target nomination assays through its SeQure service for adenine and cytosine base editors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.